Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy

Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy is a phase 3, randomised interventional study registered as NCT06857773 by The Netherlands Cancer Institute, with a registry enrolment figure of 306 participants, started 2024-11-21 and due to reach its primary completion in 2030-01. Interventions recorded: Intra arterial infusion Floxuridine (FUDR) combined with systemic therapy; Hepatic arterial infusion pump (HAIP); Systemic therapy (standard of care). Conditions listed: Colorectal Neoplasms; Floxuridine; Liver Metastases; Vascular Access Device. Primary outcome: Overall survival. Colorectal eligibility wording from the registry: "* Histologically confirmed colorectal adenocarcinoma". Sites: Netherlands. No results are recorded here; the registry entry is the source.